Why Should Hannity Have to Disclose His HUD-Backed Real-Estate Empire?

Prothena’s lead drug has decisively failed a crucial Phase IIb study for rare, second-line cases of AL amyloidosis. And after concluding that their Phase III for frontline use is also headed to failure, the biotech’s executive team is scrapping the whole program.Last Monday a judge forced Michael Cohen, President Trump’s longtime fixer and attorney-sort-of-at-law, to reveal that Sean Hannity is his client. Naturally, the mainstream media was quick to denounce the Fox News host for routinely railing against the federal investigation of Cohen, without ever disclosing the nature of their relationship.

Prothena’s lead drug has decisively failed a crucial Phase IIb study for rare, second-line cases of AL amyloidosis. And after concluding that their Phase III for frontline use is also headed to failure, the biotech’s executive team is scrapping the whole program. read more

Read More Interesting News

Why Should Hannity Have to Disclose His HUD-Backed Real-Estate Empire?